Locations:
Search
Cleveland Clinic, the University of Minnesota and University of Cambridge receive $1M grant to develop point-of-care biosensor for early detection and treatment personalization
Researchers develop first-of-its-kind neoantigen atlas to better understand immunotherapy resistance
Key research findings to watch
Recurrence and outcomes for stage II disease are worse than in ever-smokers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement